Follow The Filings

MCK McKesson

Health Care, filed as MCKESSON CORP (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

Bought by 1 manager in 2026 Q2, sold by 2

  • 3 Owners
  • Max 9.2%
  • $349M
  • 1 add 1 reduce 1 exit 1 small

In 2026 Q2 Mala Gaonkar added to McKesson, Stephen Mandel trimmed, and Farallon Capital Management sold out.

Who owns this now

Largest portfolio weights among holders, up to 9.2% (Mala Gaonkar, Surgocap Partners). Not free-float ownership.

  1. Mala Gaonkar Add 9.2%
  2. Muhlenkamp & Co. Add 6.0%
  3. Stephen Mandel Reduce 0.27%

Who owns MCK

Sorted by value, long equity only, as of 2026 Q2.

History
Mala Gaonkar, Surgocap Partners 9.2% Add +8.1% 376,870 $285M History
Stephen Mandel, Lone Pine Capital 0.27%, was 2.7% Reduce −85.3% 57,851 $44M History
Muhlenkamp & Co. 6.0% Small add +0.1% 27,202 $21M History
Farallon Capital Management exited 2026 Q2 Last 2026 Q1 1.2% Exit −1.16% 234,300 $203M History

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by MCK's executives, directors and 10% owners in the last 12 months, from their Form 4s

All MCK insider trades
  • None no insider bought on the open market
  • $597K sold by 2 insiders outside a trading plan
  • $28.5M sold by 6 insiders under 10b5-1 plans
  1. Francisco Fraga EVP, CIO and CTO
    Planned sale
    $797K 800 shares at $995.80 13% of stake
    Traded Oct 15 Filed Oct 19
  2. Napoleon B Rutledge Jr. SVP, Controller & CAO
    Planned sale
    $99K 111 shares at $891.45 18% of stake
    Traded Sep 8 Filed Sep 10
  3. Bradley E Lerman Director
    Sale
    $269K 301 shares at $892.33 100% of stake
    Traded Aug 10 Filed Aug 11
  4. Brian S. Tyler CEO
    Planned sale
    $6.7M 8,463 shares at $793.56 59% of stake
    Traded Jul 7 Filed Jul 8
  5. Brian S. Tyler CEO
    Planned sale
    $6.6M 8,463 shares at $775.13 37% of stake
    Traded Jun 17 Filed Jun 18
  6. Brian S. Tyler CEO
    Planned sale
    $3.8M 4,929 shares at $763.00 18% of stake
    Traded Jun 9 Filed Jun 11
  7. Napoleon B Rutledge Jr. SVP, Controller & CAO
    Planned sale
    $102K 133 shares at $764.00 17% of stake
    Traded Jun 5 Filed Jun 8
  8. Thomas L Rodgers EVP, Chief Strategy & BDO
    Planned sale
    $604K 822 shares at $735.30 27% of stake
    Traded Jun 1–2 Filed Jun 3
  9. LeAnn B Smith EVP & Chief HR Officer
    Planned sale
    $1.3M 1,810 shares at $735.50 27% of stake
    Traded Jun 1 Filed Jun 2
  10. Michele Lau EVP and Chief Legal Officer
    Planned sale
    $2.7M 3,550 shares at $761.09 52% of stake
    Traded May 26 Filed May 27
  11. Thomas L Rodgers EVP, Chief Strategy & BDO
    Planned sale
    $1.8M 2,388 shares at $761.09 44% of stake
    Traded May 26 Filed May 27
  12. Michele Lau EVP and Chief Legal Officer
    Planned sale
    $2.7M 2,725 shares at $990.00 46% of stake
    Traded Mar 2 Filed Mar 4
  13. Maria Martinez Director
    Sale
    $328K 349 shares at $939.87 54% of stake
    Traded Feb 19 Filed Feb 23
  14. LeAnn B Smith EVP & Chief HR Officer
    Planned sale
    $180K 190 shares at $945.00 6% of stake
    Traded Feb 17 Filed Feb 18
  15. Michele Lau EVP and Chief Legal Officer
    Planned sale
    $283K 303 shares at $933.39 4.8% of stake
    Traded Feb 11 Filed Feb 13

Also filed in the last 12 months, not counted as buying or selling: 31 share withholdings for taxes, 23 option exercises, and 11 stock grants.

Congress

15 members of Congress traded MCK in the last three years: 21 buys and 16 sales. 12 members listed it in 2025 annual reports.

All Congress trades
  1. Alan Armstrong R-OK Buy $1K–$15K Mar 27 filed Jul 21
  2. Jonathan L. Jackson D-IL-1Spouse Sell $1K–$15K Jun 15 filed Jul 15
  3. Rick Larsen D-WA-2 Buy $1K–$15K Jul 8 filed Jul 12
  4. Ritchie Torres D-NY-15 Buy $1K–$15K Jan 7, 2025 filed Jul 8
  5. Lizzie Fletcher D-TX-7 Partial sale $1K–$15K Apr 8 filed May 1
  6. Markwayne Mullin R-OKJoint Buy $15K–$50K Feb 4 filed Mar 2

SEC filings

Recent issuer filings from EDGAR, 10 shown.

Filed Form Detail Links
8-K 7.01,9.01
8-K 7.01,9.01
8-K 2.02,9.01
10-Q
8-K 5.07
8-K 5.02,7.01,9.01
DEFA14A
DEF 14A
8-K 1.01,2.03,9.01
DEFA14A

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025 FY2026
Revenue $276.71B $308.95B $359.05B $403.43B
Gross profit $12.36B $12.83B $13.32B $14.55B
Gross margin * 4.5% 4.2% 3.7% 3.6%
Net income $3.56B $3B $3.3B $4.76B
Net margin * 1.3% 1.0% 0.9% 1.2%

Balance sheet

Metric FY2023 FY2024 FY2025 FY2026
Total current assets $44.29B $47.97B $55.4B $57.21B
Total non-current assets * $18.03B $19.47B $19.74B $25.11B
Total assets $62.32B $67.44B $75.14B $82.32B
Total current liabilities $47.96B $52.36B $61.6B $67.02B
Total equity -$1.86B -$1.97B -$2.07B -$2.17B

Cash flow

Metric FY2023 FY2024 FY2025 FY2026
Cash from operations $5.16B $4.31B $6.08B $6.16B
Cash from investing -$0.542B -$1.07B -$0.733B -$3.43B
Cash from financing -$4.37B -$3.34B -$3.96B -$4.63B
Net change in cash $0.744B -$0.094B $1.37B -$1.89B

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.